Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Meghan Fitzgerald currently holds 38,578 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Meghan Fitzgerald has been a net seller of ROIV stock. They have purchased $80.1K and sold $6.0M worth of shares.
Meghan Fitzgerald's most recent insider trade was on Jun 30, 2026, when they sold 10,000 shares at $0.00 per share.
Meghan Fitzgerald serves as Executive at Roivant Sciences Ltd. (ROIV). They have executed 41 insider transactions totaling $6.1M over their tenure at the company.
Meghan Fitzgerald holds the position of Executive at Roivant Sciences Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Meghan Fitzgerald has shown a selling trading pattern, with $80.1K in total purchases and $6.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Meghan Fitzgerald was on Aug 6, 2024, when they sold $2.9M worth of THC shares. This transaction involved 20,000 shares at $146.34 per share.
Meghan Fitzgerald currently owns 38,578 shares of Roivant Sciences Ltd. (ROIV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Meghan Fitzgerald's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Meghan Fitzgerald has 41 Form 4 filings on record as an insider at Roivant Sciences Ltd..
Set alerts for Meghan Fitzgerald and 40,000+ other insiders.